Moxilen (Amoxicillin)

Amoxicillin works by binding to penicillin‑binding proteins on the bacterial cell wall, inhibiting the transpeptidation step of peptidoglycan synthesis. This weakens the cell wall, causing osmotic lysis and death of susceptible bacteria. Its activity is time‑dependent, relying on serum concentrations remaining above the minimum inhibitory concentration for the target organism.

The dosage of Moxilen is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, renal function and local antimicrobial guidelines. The prescriber selects the appropriate amount, frequency and duration of intravenous or intramuscular administration for each individual case.

Safety data for amoxicillin in pregnancy are limited, and the product is classified as pregnancy category unknown. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus. Breastfeeding mothers should consult a healthcare professional, as small amounts may be excreted in milk.

To request Moxilen, visit the product page on gnhindia.com, enter the required quantity and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and assistance with import documentation.

Compared with broader‑spectrum agents such as ceftriaxone, amoxicillin (Moxilen) offers a narrower spectrum focused on many Gram‑positive and some Gram‑negative organisms, often with a favorable safety profile and lower cost. Choice of therapy depends on local resistance patterns, infection site and patient‑specific factors.

Moxilen must be stored at 2‑8 °C in a refrigerator, protected from light and moisture. Do not freeze or shake the vial. Before administration, allow the product to reach room temperature if required, and inspect for particulate matter or discoloration. Follow aseptic technique during preparation.

Moxilen is supplied as a sterile solution for intramuscular or intravenous injection. The healthcare professional selects the appropriate route, dilutes the product if required, and administers it using aseptic technique. Dosage and infusion rate are determined by the prescriber according to the infection being treated and patient characteristics.

The most serious adverse reactions include anaphylactic or severe allergic responses, Stevens‑Johnson syndrome or toxic epidermal necrolysis, and Clostridioides difficile‑associated colitis. Prompt recognition of symptoms such as rash, difficulty breathing, severe diarrhea or fever is essential, and treatment should be discontinued and medical care sought immediately.

Patients with a documented hypersensitivity to amoxicillin, other penicillins, or any component of the formulation should avoid Moxilen. Caution is also advised for individuals with a history of severe allergic reactions, renal impairment requiring dose adjustment, or those taking medications that may interact significantly without close monitoring.